Renaissance Technologies - MERSANA THERAPEUTICS INC ownership

MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 2 filers reported holding MERSANA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of MERSANA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,176
-65.9%
925,919
-11.6%
0.00%
-60.0%
Q2 2023$3,448
-32.9%
1,047,919
-16.2%
0.01%
-28.6%
Q1 2023$5,140
+53.4%
1,250,519
+118.7%
0.01%
+40.0%
Q4 2022$3,350
-99.9%
571,719
-18.2%
0.01%
-28.6%
Q3 2022$4,724,000
+79.3%
698,819
+22.5%
0.01%
+133.3%
Q2 2022$2,635,000
-28.2%
570,319
-38.0%
0.00%
-25.0%
Q1 2022$3,668,000
+72.1%
919,200
+168.3%
0.00%
+33.3%
Q4 2021$2,131,000
+60.1%
342,600
+379.2%
0.00%
+200.0%
Q3 2020$1,331,000
-83.3%
71,500
-79.0%
0.00%
-85.7%
Q2 2020$7,962,000
+74.3%
340,268
-56.6%
0.01%
+75.0%
Q1 2020$4,568,000
+10.8%
783,568
+8.9%
0.00%
+33.3%
Q4 2019$4,124,000
+240.5%
719,768
-6.1%
0.00%
+200.0%
Q3 2019$1,211,000
+12.4%
766,725
+188.2%
0.00%0.0%
Q2 2019$1,077,000
+17.3%
266,020
+52.4%
0.00%0.0%
Q1 2019$918,000174,5200.00%
Other shareholders
MERSANA THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 8,663,673$40,026,0004.69%
Opaleye Management Inc. 1,047,000$4,837,0002.18%
Sarissa Capital Management LP 4,299,297$19,863,0002.00%
Decheng Capital Management III (Cayman), LLC 904,268$4,178,0001.58%
SILVERARC CAPITAL MANAGEMENT, LLC 850,000$3,927,0001.21%
Orbimed Advisors 9,011,437$41,633,0000.75%
Avoro Capital Advisors LLC 7,550,000$34,881,0000.69%
Rock Springs Capital Management LP 4,075,958$18,831,0000.55%
Artal Group S.A. 2,200,000$10,164,0000.54%
DAFNA Capital Management LLC 406,763$1,879,0000.51%
View complete list of MERSANA THERAPEUTICS INC shareholders